James R. Burton, Jr., MD
Department of Medicine, Division of Gastroenterology and Hepatolo
At a time when Hepatitis C treatment is rapidly evolving, Dr. Burton is playing a leading role in developing protocols for post-transplant patients trying to fend off recurrence of the disease. Since 2008, he has treated more than 200, often applying novel therapy combinations never before used in post-transplant patients. In collaboration with five other transplant centers around the country, he has amassed the largest cohort in existence on this unique, difficult-to-treat population, paving the way for research on drug interactions, side effects and overall virologic efficacy.
He works with patients daily, as Medical Director of the University of Colorado Hospital Liver Transplant Program, is conducting several trials of new antiviral drugs against Hepatitis C , and is the primary
investigator from CU for the multi-center NIH-funded Adult to Adult Living Donor Liver Transplant Cohort Study. In 2012, 5280 Magazine named Dr. Burton the top transplant hepatologist in Denver.